NovoCure Ltd — Director's Dealing 2019

Jul 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-07-18

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-18	Ordinary Shares	M	7500	$27.60	Acquired	84476	Direct
2019-07-18	Ordinary Shares	S	7500	$70.00	Disposed	76976	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-18	Options to Buy Ordinary Shares	$27.60	M	7500	Disposed	2028-04-30	Ordinary Shares (7500)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.

F2: Fully vested as of the date hereof.